← Eichor
Study identifier: NCT04731857 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes

Condition: Rare Diseases · Genetic Predisposition  ·  Sponsor: University Hospital Tuebingen

PhaseN/A
Planned participants12000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

For the retrospective data analysis, patients with genetic diseases of any age and, if available, other family members, for whom genetic analyzes were carried out between 10/2016 and 12/2020, should be included. This equates to approximately 13,000 records, minus combined analyzes in the same patient, an estimated 12,000 individuals.

This description comes directly from the study's public registry record.

Talk to the study team

Tobias Haack, Dr.  ·  +49 7071 298  ·  tobias.haack@med.uni-tuebingen.de

Olaf Rieß, Prof. Dr.  ·  +49 7071 298  ·  olaf.riess@med.uni-tuebingen.de

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital TübingenTübingen, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04731857